Depletion of OSMR in the TME resulted in delayed tumor onset and tumor growth (Figure 2, B–E, and Supplemental Figure 2, B and C), confirming that stromal OSMR signaling contributes to cancer progression. The gene discussed is OSMR; the disease is neoplasm.